Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

4.2.3.2: ethanolamine-phosphate phospho-lyase

This is an abbreviated version!
For detailed information about ethanolamine-phosphate phospho-lyase, go to the full flat file.

Word Map on EC 4.2.3.2

Reaction

Ethanolamine phosphate
+
H2O
=
acetaldehyde
+
NH3
+
phosphate

Synonyms

AGXT2L1, amino alcohol O-phosphate phospholyase, EC 4.2.99.7, ETNPPL, O-phosphoethanolamine phospho-lyase, O-phosphoethanolamine-phospholyase, O-phosphorylethanol-amine phospho-lyase, PEA phospho-lyase, phospho-lyase, ethanolamine phosphate

ECTree

     4 Lyases
         4.2 Carbon-oxygen lyases
             4.2.3 Acting on phosphates
                4.2.3.2 ethanolamine-phosphate phospho-lyase

Disease

Disease on EC 4.2.3.2 - ethanolamine-phosphate phospho-lyase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Brain Injuries
Social stress increases expression of hemoglobin genes in mouse prefrontal cortex.
Carcinoma
AGXT2L1 is down-regulated in heptocellular carcinoma and associated with abnormal lipogenesis.
AGXT2L1 is downregulated in carcinomas of the digestive system.
Carcinoma, Hepatocellular
AGXT2L1 is downregulated in carcinomas of the digestive system.
Colorectal Neoplasms
AGXT2L1 is downregulated in carcinomas of the digestive system.
Glioblastoma
Transformation Foci in IDH1-mutated Gliomas Show STAT3 Phosphorylation and Downregulate the Metabolic Enzyme ETNPPL, a Negative Regulator of Glioma Growth.
Glioma
Transformation Foci in IDH1-mutated Gliomas Show STAT3 Phosphorylation and Downregulate the Metabolic Enzyme ETNPPL, a Negative Regulator of Glioma Growth.
Liver Neoplasms
AGXT2L1 is down-regulated in heptocellular carcinoma and associated with abnormal lipogenesis.
Neoplasms
AGXT2L1 is down-regulated in heptocellular carcinoma and associated with abnormal lipogenesis.
AGXT2L1 is downregulated in carcinomas of the digestive system.
Pancreatic Neoplasms
AGXT2L1 is downregulated in carcinomas of the digestive system.
Stomach Neoplasms
AGXT2L1 is downregulated in carcinomas of the digestive system.